CellR4 (Oct 2022)

Corrigendum – Targeting Toll-Like Receptor 4: a promising strategy to prevent type 1 diabetes occurrence or recurrence

M. Alibashe-Ahmed,
T. Berney,
L. Giovannoni,
E. Berishvili

Affiliations

M. Alibashe-Ahmed: Department of Surgery, Cell Isolation and Transplantation Center, University of Geneva Hospitals, Geneva, Switzerland
T. Berney: Department of Surgery, Cell Isolation and Transplantation Center, University of Geneva Hospitals, Geneva, Switzerland
L. Giovannoni: Department of Surgery, Cell Isolation and Transplantation Center, University of Geneva Hospitals, Geneva, Switzerland
E. Berishvili: Department of Surgery, Cell Isolation and Transplantation Center, University of Geneva Hospitals, Geneva, Switzerland

DOI: https://doi.org/10.32113/cellr4_202210_3330
Journal volume & issue: Vol. 10

Abstract

Corrigendum

Published in CellR4

ISSN: 2329-7042 (Online)
Publisher: Verduci Editore
Country of publisher: Italy
LCC subjects: Science
Website: https://www.cellr4.org/

About the journal